AAAAAA
Results:
1-14
|
Results: 14
Authors:
TOLMAN KG
SANDERS SW
BUCHI KN
KAROL MD
JENNINGS DE
RINGHAM GL
Citation: Kg. Tolman et al., THE EFFECTS OF ORAL DOSES OF LANSOPRAZOLE AND OMEPRAZOLE ON GASTRIC PH (VOL 24, PG 65, 1997), Journal of clinical gastroenterology, 26(3), 1998, pp. 232-233
Authors:
TOLMAN KG
SANDERS SW
BUCHI KN
KAROL MD
JENNINGS DE
RINGHAM GL
Citation: Kg. Tolman et al., THE EFFECTS OF ORAL DOSES OF LANSOPRAZOLE AND OMEPRAZOLE ON GASTRIC PH, Journal of clinical gastroenterology, 24(2), 1997, pp. 65-70
Authors:
BLUM RA
SHI H
KAROL MD
GRESKIROSE PA
HUNT RH
Citation: Ra. Blum et al., THE COMPARATIVE EFFECTS OF LANSOPRAZOLE, OMEPRAZOLE, AND RANITIDINE IN SUPPRESSING GASTRIC-ACID SECRETION, Clinical therapeutics, 19(5), 1997, pp. 1013-1023
Authors:
ROE DJ
KAROL MD
Citation: Dj. Roe et Md. Karol, AVERAGING PHARMACOKINETIC PARAMETER ESTIMATES FROM EXPERIMENTAL STUDIES - STATISTICAL-THEORY AND APPLICATION, Journal of pharmaceutical sciences, 86(5), 1997, pp. 621-624
Authors:
KAROL MD
MACHINIST JM
CAVANAUGH JM
Citation: Md. Karol et al., LANSOPRAZOLE PHARMACOKINETICS IN SUBJECTS WITH VARIOUS DEGREES OF KIDNEY-FUNCTION, Clinical pharmacology and therapeutics, 61(4), 1997, pp. 450-458
Authors:
CAVANAUGH JH
KAROL MD
Citation: Jh. Cavanaugh et Md. Karol, LACK OF PHARMACOKINETIC INTERACTION AFTER ADMINISTRATION OF LANSOPRAZOLE OR OMEPRAZOLE WITH PREDNISONE, Journal of clinical pharmacology, 36(11), 1996, pp. 1064-1071
Authors:
KAROL MD
GRANNEMAN GR
ALEXANDER K
Citation: Md. Karol et al., DETERMINATION OF LANSOPRAZOLE AND 5 METABOLITES IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 668(1), 1995, pp. 182-186
Authors:
GRANNEMAN GR
KAROL MD
LOCKE CS
Citation: Gr. Granneman et al., PHARMACOKINETIC INTERACTION BETWEEN LANSOPRAZOLE AND THEOPHYLLINE, Therapeutic drug monitoring, 17(5), 1995, pp. 460-464
Authors:
KAROL MD
MACHINIST JM
CAVANAUGH JM
Citation: Md. Karol et al., PHARMACOKINETICS OF LANSOPRAZOLE IN HEMODIALYSIS-PATIENTS, Journal of clinical pharmacology, 35(8), 1995, pp. 815-820
Authors:
KHARASCH ED
KAROL MD
LANNI C
SAWCHUK R
Citation: Ed. Kharasch et al., CLINICAL SEVOFLURANE METABOLISM AND DISPOSITION .1. SEVOFLURANE AND METABOLITE PHARMACOKINETICS, Anesthesiology, 82(6), 1995, pp. 1369-1378
Authors:
KHARASCH ED
ARMSTRONG AS
GUNN K
ARTRU A
COX K
KAROL MD
Citation: Ed. Kharasch et al., CLINICAL SEVOFLURANE METABOLISM AND DISPOSITION .2. THE ROLE OF CYTOCHROME-P450 2E1 IN FLUORIDE AND HEXAFLUOROISOPROPANOL FORMATION, Anesthesiology, 82(6), 1995, pp. 1379-1388
Authors:
MEIKLE AW
SANDERS SW
TOLMAN KG
JENNINGS DE
KAROL MD
RINGHAM GL
Citation: Aw. Meikle et al., EFFECT OF LANSOPRAZOLE ON MALE HORMONE FUNCTION, Drug investigation, 8(4), 1994, pp. 191-202
Authors:
CAVANAUGH JH
SCHNECK DW
MUKHERJI D
KAROL MD
Citation: Jh. Cavanaugh et al., LACK OF EFFECT OF CONCOMITANT LANSOPRAZOLE ON SINGLE-DOSE PROPRANOLOLPHARMACOKINETICS AND PHARMACODYNAMICS, Gastroenterology, 106(4), 1994, pp. 10000004-10000004
Authors:
KAROL MD
MUKHERJI D
CAVANAUGH JH
Citation: Md. Karol et al., LACK OF EFFECT OF CONCOMITANT MULTIDOSE LANSOPRAZOLE ON SINGLE-DOSE PHENYTOIN PHARMACOKINETICS IN SUBJECTS, Gastroenterology, 106(4), 1994, pp. 10000103-10000103
Risultati:
1-14
|